INCB10820

CAS No. 1310796-72-5

INCB10820( PF-4178903 | INCB 10820 )

Catalog No. M11249 CAS No. 1310796-72-5

INCB10820 (PF-4178903) is a potent, selective, orally bioavailable dual CCR2 and CCR5 antagonist with binding IC50 of 3.0 nM and 5.3 nM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    INCB10820
  • Note
    Research use only, not for human use.
  • Brief Description
    INCB10820 (PF-4178903) is a potent, selective, orally bioavailable dual CCR2 and CCR5 antagonist with binding IC50 of 3.0 nM and 5.3 nM, respectively.
  • Description
    INCB10820 (PF-4178903) is a potent, selective, orally bioavailable dual CCR2 and CCR5 antagonist with binding IC50 of 3.0 nM and 5.3 nM, respectively; displays an IC50 of 4.3 nM in CCR5 chemotaxis functional assay; is active against mouse, rat and cynomolgus monkey CCR2 with binding IC50 of 2.8, 2.9 and 4.6 nM, respectively, but inactive against canine CCR2, also is active against mouse and cynomolgus monkey CCR5 with IC50 of 71 and 4.0 nM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PF-4178903 | INCB 10820
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1310796-72-5
  • Formula Weight
    498.591
  • Molecular Formula
    C25H37F3N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (3S,4S)-N-[(1R,3S)-3-isopropyl-3-({4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}carbonyl)cyclopentyl]-3-methoxytetrahydro-2H-pyran-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zheng C, et al. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1442-6.
molnova catalog
related products
  • CCX-354

    CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases.

  • LMD-009

    LMD-009 (LMD 009, LMD009) is a potent, selective, nonpeptide CCR8 agonist.

  • Plerixafor

    Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor.